Serum granulysin as a possible key marker of the activity of alopecia areata

Journal of Dermatological Science

Volumn 73, Issue 1, 2014, Pages 74-79

  Ono, Sachiko ^a   Otsuka, Atsushi ^a   Yamamoto, Yosuke ^a   Kataoka, Tatsuki R ^a   Koyanagi, Itsuko ^a   Miyachi, Yoshiki ^a   Kabashima, Kenji ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Activity; Allergic disorders; Alopecia areata; Cell mediated cytotoxicity; Granulysin; Prognosis

Indexed keywords

CARBON DIOXIDE; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CEPHARANTHINE; DIPHENCYPRONE; FEXOFENADINE; GRANULYSIN; HEXAMETHONIUM CHLORIDE; PREDNISOLONE; SQUARIC ACID DIBUTYL ESTER; STEROID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ALLERGIC DISEASE; ALOPECIA AREATA; ANTIBODY DETECTION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; FEMALE; HAIR FOLLICLE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; PHOTOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ULTRAVIOLET B RADIATION; YOUNG ADULT;

ACTIVITY; ALLERGIC DISORDERS; ALOPECIA AREATA; CELL-MEDIATED CYTOTOXICITY; GRANULYSIN; PROGNOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SKIN; UP-REGULATION; YOUNG ADULT;

EID: 84890129346     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.08.009     Document Type: Article

References (23)

1. Ito T. Hair follicle is a target of stress hormone and autoimmune reactions. J Dermatol Sci 2010, 60:67-73.
2. Gilhar A., Kalish R.S. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006, 5:64-69.
3. Nagao K., Kobayashi T., Moro K., Ohyama M., Adachi T., Kitashima D.Y., et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol 2012, 13:744-752.
4. Gilhar A., Etzioni A., Paus R. Alopecia areata. N Engl J Med 2012, 366:1515-1525.
5. Ito T., Ito N., Saatoff M., Hashizume H., Fukamizu H., Nickoloff B.J., et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 2008, 128:1196-1206.
6. Bodemer C., Peuchmaur M., Fraitaig S., Chatenoud L., Brousse N., De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000, 114:112-116.
7. Ono S., Otsuka A., Miyachi Y., Kabashima K. No basophil infiltration in alopecia areata irrespective of the intensity of eosinophil infiltration. Acta Derm Venereol 2013, 93:185-186.
8. Ochoa M.T., Stenger S., Sieling P.A., Thoma-Uszynski S., Sabet S., Cho S., et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001, 7:174-179.
9. Gamen S., Hanson D.A., Kaspar A., Naval J., Krensky A.M., Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998, 161:1758-1764.
10. Ogawa K., Takamori Y., Suzuki K., Nagasawa M., Takano S., Kasahara Y., et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol 2003, 33:1925-1933.
11. Sakai M., Ogawa K., Shiozaki A., Yoneda S., Sasaki Y., Nagata K., et al. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin Exp Immunol 2004, 136:114-119.
12. Nagasawa M., Isoda T., Itoh S., Kajiwara M., Morio T., Shimizu N., et al. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction. Am J Hematol 2006, 81:340-348.
13. Furudate S., Fujimura T., Kambayashi Y., Aiba S. Granulysin-bearing cells in the skin lesions of acute graft-versus-host disease: possible mechanisms for hypohidrosis in graft-versus-host disease. Case Rep Dermatol 2013, 5:93-98.
14. Kambayashi Y., Fujimura T., Furudate S., Hashimoto A., Haga T., Aiba S. Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma. Dermatology 2013.
15. Sekiguchi N., Asano N., Ito T., Momose K., Momose M., Ishida F. Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms. Int J Hematol 2012, 96:461-468.
16. Dy L.C., Whiting D.A. Histopathology of alopecia areata, acute and chronic: why is it important to the clinician?. Dermatol Ther 2011, 24:369-374.
17. Sato-Kawamura M., Aiba S., Tagami H. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res 2003, 294:536-543.
18. Chung W.H., Hung S.I., Yang J.Y., Su S.C., Huang S.P., Wei C.Y., et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008, 14:1343-1350.
19. Abe R., Yoshioka N., Murata J., Fujita Y., Shimizu H. Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 2009, 151:514-515.
20. Fujita Y., Yoshioka N., Abe R., Murata J., Hoshina D., Mae H., et al. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol 2011, 65:65-68.
21. Alkhalifah A., Alsantali A., Wang E., McElwee K.J., Shapiro J. Alopecia areata update. Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010, 62:177-188. (quiz 189-190).
22. Kaufman G., d'Ovidio R., Kaldawy A., Assy B., Ullmann Y., Etzioni A., et al. An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?. Exp Dermatol 2010, 19:e347-e349.
23. Betz R.C., Pforr J., Flaquer A., Redler S., Hanneken S., Eigelshoven S., et al. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol 2007, 127:2539-2543.